Mild Cognitive Impairment (MCI) Treatment Market growing with a CAGR of 10.1% forecast to 2029 by Disease Type, Treatment Type, Route Of Administration, Drug Type, Gender Type, Age Type, End User
The mild cognitive impairment (MCI) treatment market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.1% in the forecast period of 2022 to 2029 and is expected to reach USD 24,974.93 thousand by 2029. Wide portfolio offered by major players and growing awareness of mild cognitive impairment is expected to act as driver for the market growth.